Expertise in
27
conditions

Shigeru Y. Saito

Kamakura, JP 
Expertise in
27
conditions
Kamakura, JP 

Overview

Shigeru Saito practices practicing medicine in Kamakura, Japan.

Mr. Saito is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Preeclampsia, High Blood Pressure in Infants, Percutaneous Coronary Intervention (PCI), and Lithotripsy.

He is actively involved in clinical research, co-authoring 746 peer reviewed articles and participating in 10 clinical trials.

Gender

Male

Locations

Kamakura, Japan
Other Locations
Maebashi, Japan
Toyama, Japan
Sugitani, Japan
Okazaki, 4448787, Japan
3191195, Japan
Tokyo, 1848795, Japan
Okinawa, Japan
Nagahama, 5260829, Japan
Shizuoka, 4228526, Japan
Chiba, Japan
Kawasaki, Japan
Yonago, Japan
Tomioka, Japan
Sapporo, Japan
Mitaka, 1818588, Japan
Matsumoto, Japan
Tokai, 3191106, Japan
Atsugi, 2430198, Japan
Kyoto, 6068507, Japan
Kobe, Japan
Kiryu, 3768515, Japan
Okayama, Japan
Yokohama, Japan
Shibuya, 1500001, Japan
Honjo, 8608556, Japan
Shiojiri, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Enrollment Status: Completed
Publish Date: July 30, 2026
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2026
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Device, Drug
Study Phase: Not Applicable
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Device
Study Phase: Not Applicable
AltaValve Early Feasibility Study Protocol
AltaValve Early Feasibility Study Protocol
Enrollment Status: Unknown
Publish Date: September 01, 2023
Intervention Type: Device
Study Phase: Not Applicable
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
DISCO Radial Trial: DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention: a Randomized Multicenter Trial
DISCO Radial Trial: DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention: a Randomized Multicenter Trial
Enrollment Status: Completed
Publish Date: May 24, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Enrollment Status: Unknown
Publish Date: October 08, 2019
Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Pacific Population
Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Pacific Population
Enrollment Status: Completed
Publish Date: September 25, 2019
Intervention Type: Device
View 9 Less Clinical Trials

746 Total Publications

Clinical Outcomes After Drug-Eluting Stent Thrombosis in Patients on Hemodialysis　- Insights From the REAL-ST Registry.
Clinical Outcomes After Drug-Eluting Stent Thrombosis in Patients on Hemodialysis　- Insights From the REAL-ST Registry.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: June 17, 2026

Frequently Asked Questions about Shigeru Y. Saito

Is Shigeru Y. Saito a top-rated expert for Percutaneous Coronary Intervention (PCI)?

MediFind is an objective health platform that identifies experts based on real-world data. Shigeru Y. Saito is classified as an Elite expert for Percutaneous Coronary Intervention (PCI), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shigeru Y. Saito participate in research or clinical trials?

Yes. Shigeru Y. Saito has published 746 articles and abstracts on conditions like Percutaneous Coronary Intervention (PCI). You can view a list of Shigeru Y. Saito's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Saito's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 17 Advanced Conditions
View All 125 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile